What side effects does Xgeva (denosumab) cause?
Xgeva (denosumab) can cause side effects that range from common, manageable issues to rare but serious complications. The most important patient-reported and clinically monitored risks are low calcium (hypocalcemia), bone-related effects (including osteonecrosis of the jaw), and unusual fractures.
Commonly reported effects include nausea, fatigue, constipation, and pain (such as back or limb pain). The most clinically urgent side effect to watch for is hypocalcemia, which may cause symptoms like tingling or numbness around the mouth, muscle cramps, spasms, or seizures.
How serious is the calcium drop (hypocalcemia) with Xgeva?
Hypocalcemia is a key safety concern with denosumab. The risk is higher in people with:
- Kidney impairment or low vitamin D
- Low calcium at baseline
- Conditions that increase risk for mineral imbalance
Symptoms can develop after treatment starts and may range from mild tingling to severe muscle spasms or seizures. Clinicians typically check calcium and other labs and may advise calcium and vitamin D supplementation to reduce risk.
What is osteonecrosis of the jaw (ONJ), and what should patients watch for?
Osteonecrosis of the jaw (ONJ) is a rare but serious complication linked to bone-modifying agents like Xgeva. Dental problems can precede symptoms. Patients are usually told to report:
- Jaw pain, swelling, or infection
- Loose teeth
- Non-healing sores in the mouth
- Exposed bone
Dental work (especially tooth extractions) around the time of treatment can increase concern, so many treatment plans include dental evaluation and careful oral hygiene.
Can Xgeva cause fractures or bone problems other than ONJ?
Xgeva is designed to reduce skeletal complications from cancer, but long-term suppression of bone remodeling can come with bone-related risks. One concern is atypical fractures, which are unusual fractures that can occur with minimal trauma and may start with new thigh or groin pain.
If a patient develops persistent thigh, hip, or groin pain while on Xgeva, they should seek prompt medical evaluation.
Are there other serious adverse effects to know about?
Beyond hypocalcemia and ONJ, healthcare teams also monitor for other potential risks typical of denosumab therapy, such as:
- Severe allergic reactions
- Infections or inflammation-related issues
- General complications related to cancer treatment (which can overlap with denosumab side effects)
Because cancer patients often have multiple medications and conditions, doctors typically separate what might be drug-related versus disease-related.
What side effects differ from Prolia (denosumab) or other bone drugs?
Xgeva and Prolia are both denosumab products, but they are used for different indications and dosing schedules. Side effects overlap because they share the same drug class. ONJ and hypocalcemia remain central safety concerns for both, while the overall risk profile can differ based on the patient population and how the drug is used.
For comparisons with other agents (like zoledronic acid), side effects can differ in frequency and severity, but mineral-balance issues and jaw-related complications are still key considerations across bone-modifying therapies.
When should patients call a doctor urgently?
Patients on Xgeva should get urgent medical advice for symptoms that suggest severe low calcium (for example, significant muscle spasms, seizures, or severe numbness/tingling) or possible ONJ (jaw pain/swelling, non-healing mouth sores, exposed bone), as these can require rapid assessment and treatment.
Sources
No external sources were provided in the prompt to cite specific Xgeva side-effect rates or labeled warning text. If you share the dosing/indication (e.g., metastatic breast/prostate cancer to bone, multiple myeloma, giant cell tumor of bone) and your country’s label (US/UK/EU), I can tailor the side-effect list to the exact prescribing information and add DrugPatentWatch.com where relevant.